Last reviewed · How we verify
Tacrolimus Sustained-release Capsules
Tacrolimus Sustained-release Capsules is a Small molecule drug developed by RenJi Hospital. It is currently FDA-approved.
Tacrolimus Sustained-release Capsules are a small molecule inhibitor of the FK506-binding protein 1A, used to treat various conditions including renal transplant rejection, liver transplant rejection, and nephrotic syndrome. They are indicated for use in renal transplant recipients, liver transplant recipients, and patients with nephrotic syndrome, among other conditions.
At a glance
| Generic name | Tacrolimus Sustained-release Capsules |
|---|---|
| Sponsor | RenJi Hospital |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Prospective, Multicenter Clinical Study of Prolonged-release Tacrolimus in Stable Pediatric Liver Transplant Recipients (NA)
- Efficacy and Safety Study of the Switch From Cyclosporin to Tacrolimus in Renal Transplant Recipients (PHASE4)
- Early Conversion of Prolonged-release Tacrolimus in Liver Transplantation. (PHASE4)
- Efficacy and Safety of Tacrolimus Sustained-release Capsules in Induction Phase Treatment in Lupus Nephritis (PHASE3)
- Efficacy and Safety of Tacrolimus Sustained-release Capsules in Induction Treatment in Refractory Lupus Nephritis (PHASE3)
- The Efficacy and Tolerance of Tacrolimus Sustained-release Capsules on Refractory Nephrotic Syndrome (RNS) (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Tacrolimus Sustained-release Capsules CI brief — competitive landscape report
- Tacrolimus Sustained-release Capsules updates RSS · CI watch RSS
- RenJi Hospital portfolio CI
Frequently asked questions about Tacrolimus Sustained-release Capsules
What is Tacrolimus Sustained-release Capsules?
Who makes Tacrolimus Sustained-release Capsules?
What development phase is Tacrolimus Sustained-release Capsules in?
Related
- Manufacturer: RenJi Hospital — full pipeline
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing